Expert US stock analyst coverage consensus and rating distribution analysis to understand market sentiment and Wall Street expectations for specific stocks. We aggregate analyst opinions to provide a consensus view of Wall Street expectations including price targets and ratings. We provide consensus ratings, price target analysis, and analyst sentiment for comprehensive coverage. Understand market expectations with our comprehensive analyst coverage and consensus analysis tools for sentiment investing.
Collegium Pharmaceutical Inc. (COLL) is a specialty pharmaceutical company whose shares are trading at $34.93 as of 2026-04-15, marking a 1.99% decline in recent trading. This analysis breaks down current market context for the stock, key technical levels to monitor, and potential near-term price scenarios, without making any investment recommendations. No recent earnings data is available for COLL at the time of writing, so recent price action has been driven primarily by broader market and sec
Collegium (COLL) Recovery Signs? (Smart Money Outflows) - Senior Analyst Forecasts
COLL - Stock Analysis
3,821 Comments
870 Likes
1
Ciane
Daily Reader
2 hours ago
I feel like I should take notes… but won’t.
👍 236
Reply
2
Tyrus
Community Member
5 hours ago
This deserves attention, I just don’t know why.
👍 118
Reply
3
Latalia
Trusted Reader
1 day ago
I read this like I had a deadline.
👍 284
Reply
4
Catonya
Experienced Member
1 day ago
This feels like something important happened.
👍 244
Reply
5
Adrainne
Loyal User
2 days ago
I’m reacting before processing.
👍 297
Reply
Disclaimer: Not investment advice. For informational purposes only. Past performance does not guarantee future results. Trading involves substantial risk of loss.